Screening compound: QEZLZFJUMWBCRU-IBGZPJMESA-N

Screening compound: QEZLZFJUMWBCRU-IBGZPJMESA-N
Screening compound: QEZLZFJUMWBCRU-IBGZPJMESA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
QEZLZFJUMWBCRU-IBGZPJMESA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L632-1063

Molecular Formula

C27H35N5O4 (C27 H35 N5 O4)

Compound Name

N-cyclopropyl-1-{5-[3-(4-methoxyphenyl)propanoyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carbonyl}piperidine-3-carboxamide

IUPAC name

N-cyclopropyl-1-{5-[3-(4-methoxyphenyl)propanoyl]-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carbonyl}piperidine-3-carboxamide

SMILES

Cn1nc(C(N(CCC2)CC2C(NC2CC2)=O)=O)c(C2)c1CCN2C(CCc(cc1)ccc1OC)=O

InChI

InChI=1S/C27H35N5O4/c1-30-23-13-15-31(24(33)12-7-18-5-10-21(36-2)11-6-18)17-22(23)25(29-30)27(35)32-14-3-4-19(16-32)26(34)28-20-8-9-20/h5-6,10-11,19-20H,3-4,7-9,12-17H2,1-2H3,(H,28,34)/t19-/m0/s1

InChI Key

QEZLZFJUMWBCRU-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27643455

QEZLZFJUMWBCRU-IBGZPJMESA-N in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

MCL1 Targeted Library (12200 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with QEZLZFJUMWBCRU-IBGZPJMESA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound QEZLZFJUMWBCRU-IBGZPJMESA-N?
Check Price and Availability of QEZLZFJUMWBCRU-IBGZPJMESA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of QEZLZFJUMWBCRU-IBGZPJMESA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for QEZLZFJUMWBCRU-IBGZPJMESA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for QEZLZFJUMWBCRU-IBGZPJMESA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of QEZLZFJUMWBCRU-IBGZPJMESA-N available by request